09/05/2024
3:28 PM | Karyopharm Therapeutics (Issuer)
Mano Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
3:13 PM | Cheng Sohanya Roshan (Reporting)
Karyopharm Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
3:24 PM | Karyopharm Therapeutics (Issuer)
Mason Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
3:26 PM | Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
3:05 PM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
3:31 PM | Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
6:33 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
08/06/2024
6:42 AM | Karyopharm Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/31/2024
3:14 PM | Karyopharm Therapeutics (Issuer)
Poulton Stuart (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
3:07 PM | Karyopharm Therapeutics (Subject)
| Form SC TO-I/A | |
07/09/2024
3:15 PM | Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2024
3:32 PM | BlackRock Inc. (Filed by)
Karyopharm Therapeutics (Subject)
| Form SC 13G/A | |
06/20/2024
7:01 AM | Karyopharm Therapeutics (Subject)
| Form SC TO-I | |
06/09/2024
11:15 PM | Karyopharm Therapeutics (Filer)
| Form EFFECT | |
06/07/2024
6:18 PM | Karyopharm Therapeutics (Issuer)
PAKIANATHAN DEEPIKA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
5:51 PM | Karyopharm Therapeutics (Issuer)
PAKIANATHAN DEEPIKA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
7:00 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/30/2024
4:32 PM | Karyopharm Therapeutics (Issuer)
Oliger Christy J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
4:19 PM | BOHLIN GAREN G (Reporting)
Karyopharm Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
4:25 PM | Greene Barry E (Reporting)
Karyopharm Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
4:32 PM | Karyopharm Therapeutics (Issuer)
Mirza Mansoor Raza (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
4:32 PM | Karyopharm Therapeutics (Issuer)
PAKIANATHAN DEEPIKA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
4:32 PM | Karyopharm Therapeutics (Issuer)
Schor Chen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
4:32 PM | Karyopharm Therapeutics (Issuer)
Su Zhen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
3:44 PM | Karyopharm Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
05/14/2024
3:06 PM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
3:13 PM | Karyopharm Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/08/2024
6:47 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
6:52 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
3:56 PM | Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2024
6:55 AM | Karyopharm Therapeutics (Filer)
| Form ARS | |
04/19/2024
6:36 AM | Karyopharm Therapeutics (Filer)
| Form DEF 14A | |
04/19/2024
6:44 AM | Karyopharm Therapeutics (Filer)
| Form DEFA14A | |
04/08/2024
4:08 PM | Karyopharm Therapeutics (Subject)
| Form SC TO-C | |
04/08/2024
3:40 PM | Karyopharm Therapeutics (Filer)
| Form PRE 14A | |
04/05/2024
4:20 PM | Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
6:36 PM | Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
6:37 PM | Cheng Sohanya Roshan (Reporting)
Karyopharm Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
6:38 PM | Karyopharm Therapeutics (Issuer)
Mano Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
6:39 PM | Karyopharm Therapeutics (Issuer)
Mason Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
6:40 PM | Karyopharm Therapeutics (Issuer)
Poulton Stuart (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
$2 Trillion Disappears Because of Fed's Secretive New Move (Ad) $2 trillion has disappeared from the US government's books.
The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth. Click here to see his new research now. |
03/04/2024
6:41 PM | Karyopharm Therapeutics (Issuer)
Rangwala Reshma (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:34 PM | Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:35 PM | Cheng Sohanya Roshan (Reporting)
Karyopharm Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:35 PM | Karyopharm Therapeutics (Issuer)
Mano Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:35 PM | Karyopharm Therapeutics (Issuer)
Mason Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:35 PM | Karyopharm Therapeutics (Issuer)
Poulton Stuart (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:36 PM | Karyopharm Therapeutics (Issuer)
Rangwala Reshma (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
6:43 AM | Karyopharm Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/29/2024
6:35 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/20/2024
7:00 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
9:33 AM | Avidity Partners Management LP (Filed by)
Karyopharm Therapeutics (Subject)
| Form SC 13G/A | |
02/12/2024
5:06 AM | Karyopharm Therapeutics (Subject)
Rubric Capital Management LP (Filed by)
| Form SC 13G/A | |
02/08/2024
3:36 PM | Karyopharm Therapeutics (Issuer)
Mason Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2024
6:40 PM | Cheng Sohanya Roshan (Reporting)
Karyopharm Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2024
5:43 PM | Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2024
5:47 PM | Karyopharm Therapeutics (Issuer)
Mason Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2024
5:53 PM | Karyopharm Therapeutics (Issuer)
Mano Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2024
6:14 PM | Karyopharm Therapeutics (Issuer)
Poulton Stuart (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2024
6:16 PM | Karyopharm Therapeutics (Issuer)
Rangwala Reshma (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
12:50 PM | Karyopharm Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/08/2024
8:00 PM | Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
7:40 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/08/2023
7:00 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/08/2023
7:00 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2023
4:03 PM | Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2023
4:32 PM | Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/02/2023
6:57 AM | Karyopharm Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/02/2023
6:37 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
